Curon’s Secca System For Fecal Incontinence Receives 510(k) Clearance
This article was originally published in The Gray Sheet
Executive Summary
Curon Medical's 12 sales reps will market the Secca system for the treatment of fecal incontinence. FDA 510(k) clearance was announced March 25
You may also be interested in...
Oceana To Launch Solesta For Fecal Incontinence By September
Oceana Therapeutics plans to double its sales force over the summer by hiring 10 additional reps in preparation for a September launch of its newly approved Solesta bulking agent for fecal incontinence.
Oceana To Launch Solesta For Fecal Incontinence By September
Oceana Therapeutics plans to double its sales force over the summer by hiring 10 additional reps in preparation for a September launch of its newly approved Solesta bulking agent for fecal incontinence.
FDA Panel Strongly Endorses Oceana's Solesta Fecal Incontinence Product
An FDA advisory panel offered strong support Dec. 2 to Ocean Therapeutics' effort to win PMA approval for its Solesta injectable bulking agent for fecal incontinence.